276 related articles for article (PubMed ID: 33897695)
1. TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.
Yang M; Huang Q; Li C; Jiang Z; Sun J; Wang Z; Liang R; Li D; Li B; Zhao H
Front Immunol; 2021; 12():647540. PubMed ID: 33897695
[TBL] [Abstract][Full Text] [Related]
2. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
3. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
4. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
6. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
7. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
[TBL] [Abstract][Full Text] [Related]
8. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
9. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
10. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
Wang Z; Kang B; Gao Q; Huang L; Di J; Fan Y; Yu J; Jiang B; Gao F; Wang D; Sun H; Gu Y; Li J; Su X
Cancer Sci; 2021 Sep; 112(9):3895-3910. PubMed ID: 34185934
[TBL] [Abstract][Full Text] [Related]
13. FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.
Liu R; Huang S; Lei Y; Zhang T; Wang K; Liu B; Nice EC; Xiang R; Xie K; Li J; Huang C
Oncotarget; 2015 Jan; 6(2):935-52. PubMed ID: 25473897
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
15. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.
Chen YH; Wei MF; Wang CW; Lee HW; Pan SL; Gao M; Kuo SH; Cheng AL; Teng CM
Cancer Lett; 2015 Feb; 357(2):582-90. PubMed ID: 25497009
[TBL] [Abstract][Full Text] [Related]
16. Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.
Zhang J; Jiang W; Liu W; Wu JJ; Song L; Cheng JX; Yao M; Yang LP; Yao DF
Future Oncol; 2016 Feb; 12(4):515-24. PubMed ID: 26776341
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
18. Decreased Expression of MPC2 Contributes to Aerobic Glycolysis and Colorectal Cancer Proliferation by Activating mTOR Pathway.
Kuerbanjiang M; Gu L; Xu C; Xu WT; Wen S; Xue H; Xu Q
J Immunol Res; 2021; 2021():6618837. PubMed ID: 33791391
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer.
Zhang YJ; Zhao SL; Tian XQ; Sun DF; Xiong H; Dai Q; Li XQ; Fang JY
Int J Colorectal Dis; 2009 Jun; 24(6):629-39. PubMed ID: 19229543
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]